With the advent of CRISPR as a gene editing technology, there are new opportunities to develop breakthrough treatments that weren’t possible before. Could this be a turning point that revolutionizes how doctors treat some of the biggest medical challenges, while also being a more effective and cheaper solution for the patient? Shengdar Q. Tsai, associate member and principal investigator of the Department of Hematology at St. Jude Children’s Research Hospital, joins The Excerpt to talk about how this new technology could shape the future of medicine.

Episode Transcript available here

Also available at art19.com/shows/5-Things

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.